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Background: Exercise and green tea supplementation have been shown to have the potential 20 
to improve postprandial blood glucose concentrations, but past interventions have not often 21 
investigated attainable and time effective exercise protocols. 22 
Aim: The purpose of this study was to investigate the effects of interval walking exercise and 23 
acute green tea extract supplementation on the glycaemic response to an oral glucose 24 
tolerance test (OGTT).  25 
Methods: Twelve physically inactive participants (9 male, 3 female, age: 22 ± 1 y; body 26 
mass: 81.2 ± 16.3 kg; stature: 175.7 ± 9.6 cm; body mass index (BMI; in kg/m2): 26.2 ± 4.3) 27 
underwent a 2-hour OGTT immediately following i) no intervention (REST), ii) placebo and 28 
exercise (EX-PLAC), ii) green tea extract supplementation and exercise (EX-GTE), in a 29 
random order. The walking exercise consisted of 6 x 1-min of brisk walking (7.92 ± 0.56 30 
km/h) separated by 1-min of slower walking (4.8 km/h). Differences between groups were 31 
identified using magnitude based inferences.  32 
Results: The EX-GTE intervention resulted in a ~9% most likely beneficial effect on blood 33 
glucose area under the curve response to the OGTT (702.18 ± 76.90 mmol/L-1.120 min-1) 34 
compared to REST (775.30 ± 86.76 mmol/L-1.120 min-1), and a very likely beneficial effect 35 
compared to the EX-PLAC (772.04 ± 81.53 mmol/L-1.120 min-1).  36 
Conclusion: These data suggest that an EX-GTE intervention can reduce postprandial 37 
glucose concentrations in physically inactive individuals.  38 






Glycaemic control is vital in the management and prevention of insulin resistant related 43 
diseases such as metabolic syndrome and type 2 diabetes mellitus (T2DM) (American 44 
Diabetes Association, 2015). Control of postprandial hyperglycaemia is essential for 45 
achieving long-term glycaemic control, defined using recommended HbA1c goals. Peak 46 
glucose concentrations typically occur ~60-90 min postprandially and, in individuals with 47 
insulin resistance, are sustained for several hours (American Diabetes Association, 2015). 48 
Glycaemic excursions, such as those following meals, correlate with HbA1c levels and have a 49 
detrimental effect, inducing oxidative stress and inflammation (Brownlee, 2005). 50 
Furthermore, HbA1c levels are directly associated with increased cardiovascular disease 51 
(CVD) risk and all cause-mortality (Brownlee, 2005); with CVD accounting for more than 52 
65% of all diabetic deaths (Lloyd-Jones et al., 2009). T2DM prevalence continues to increase 53 
among the adult population and presents a major public health challenge (Zghebi et al., 54 
2017).  55 
 56 
Obesity and a sedentary lifestyle are modifiable risk factors for the development of T2DM. 57 
Lifestyle interventions (exercise and diet modification) are therefore obvious cost-effective 58 
methods to prevent the development of T2DM and obesity. Both resistance and endurance-59 
based exercise increase whole-body glucose uptake (Koopman et al., 2005; Larsen et al., 60 
1997). However, a major barrier to exercise participation and adherence is reported ‘lack of 61 
time’, regardless of sex, age, socioeconomic status, and fitness level (Trost et al., 2002). 62 
Low-volume high-intensity interval training (HIT) has been shown to be a time-efficient 63 
stimulus to improve blood glucose in healthy and insulin resistant individuals, via a number 64 
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of different modalities (Adams, 2013). Little et al. (2011) conclude that HIT training 65 
increases muscle mitochondrial capacity and GLUT-4 protein content, rapidly improving 66 
glucose control (10 x 60-s cycling bouts). Additionally, regular HIT training (two weeks 67 
cycling intervention) may reduce obesity risk, by increasing energy expenditure and fat 68 
oxidation, enhancing weight loss, aiding in the prevention of T2DM (Whyte et al., 2010). 69 
Lower intensity interval training, such as interval-walking has also been found to be a 70 
feasible training method in T2DM participants. Karsoft et al. (2013) report high adherence 71 
rates (89 ± 4%) and significant improvements in ?̇?O2max (16.1 ± 3.7%) and glycaemic control. 72 
Moreover, Francois et al. (2014) found that even brief bouts of incline walking (6 x 1 min 73 
bouts at ~90% HRmax) prior to meals significantly improved glycaemic control in individuals 74 
with insulin resistance. 75 
 76 
Pragmatic lifestyle interventions combining physical activity and diet modifications are 77 
effective at promoting weight loss, and improve glycaemic control, potentially reducing the 78 
risk of developing T2DM and cardiovascular disease (Hordern et al., 2012). However, there 79 
is a need for more research to establish optimal strategies that are both cost-effective and 80 
attainable. Interestingly, after investigating diabetic patients’ perceptions of illness and 81 
treatments, Broadbent et al. (2011) report that 86% of patients adhered to medication, 82 
whereas, just 22% report to adhere to nutritional advice. Suggesting that nutritional 83 
supplementation may be an effective alternative to diet manipulation. Recent research has 84 
found that green tea catechin (GTC) supplementation in humans may improve risk factors 85 
related to metabolic syndrome, including increased insulin sensitivity and reduced cholesterol 86 
and adiposity (Bogdanski et al., 2012; Suliburska et al., 2012). An accessible concentrated 87 
form of the catechins that are linked to lower disease risk (Kao et al., 2006) can be found in 88 
green tea extract (GTE). Specifically, the most biologically active molecule in GTE, 89 
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epigallocatechin gallate (EGCG), is of a high concentration, accounting for ~50-80% of the 90 
total catechin content (Khan and Mukhtar, 2007). Importantly, a recent meta-analysis 91 
concluded that GTC ingestion lowers fasting blood glucose (-1.48 mg/dL; 95% CI: -2.57, -92 
0.40 mg/dL) in human adults (n = 1584) (Zheng et al., 2013), and Venables et al. (2008) have 93 
reported that just 24-hrs of green tea extract (GTE) supplementation improves glycaemic 94 
control (-15 ± 4% serum insulin AUC) after an oral glucose load in healthy men (n =11) at 95 
rest.   96 
 97 
There is limited research on the use of GTE in combination with exercise. A single study has 98 
reported that GTE supplementation attenuates the glucose and insulin responses to an oral 99 
glucose load 1 hr after a graded exercise test but not at rest (Martin et al., 2016). The exercise 100 
employed by Martin et al. (2016) was also appropriate to control workload between 101 
conditions and analyse substrate oxidation. However the translation of results from such an 102 
exercise may be limited, as individuals are unlikely to complete a graded exercise test within 103 
their regular physical activity for practical and comfort reasons. Further work is needed to 104 
build upon this proof of principle research of Martin et al. (2016), and examine if the results 105 
from laboratory tests hold true for more attainable and time efficient physical activity such as 106 
low-volume interval-walking. The aim of this study was to examine the effect of interval-107 







Materials and methods 113 
 114 
Participants 115 
Twelve participants (9 male, 3 female, age: 22 ± 1 y; body mass: 81.2 ± 16.3 kg; stature: 116 
175.7 ± 9.6 cm; body mass index (BMI; in kg/m2): 26.2 ± 4.3) were recruited for the study. 117 
All participants were considered to be physically inactive after completing a Global Physical 118 
Activity Questionnaire (GPAQ); defined by not meeting national guidelines to achieve a 119 
healthy lifestyle – 150 minutes of moderate-intensity exercise per week or 75 minutes of 120 
vigorous-intensity exercise per week. All participants gave written informed consent to 121 
participate in the study, and the study and its protocol received full ethical approval from the 122 
Faculty of Health and Life Sciences Research Ethics Committee at Northumbria University. 123 
The study contained no drop out of participants. 124 
 125 
Preliminary testing 126 
Basic anthropometric measures were taken, as well as safety measures, including, fasting 127 
blood glucose (4.41 ± 0.17 mmol/L) and systolic blood pressure (SBP; 124.7 ± 14.3 mmHg) 128 
(Omron M6 AC Blood Pressure Monitor, Omron, United Kingdom). Fasting blood glucose 129 
was collected following an overnight fast (> 8 hr) using finger capillary blood sampling, 130 
followed by blood analysis (Biosen 5030 lactate analyser, Cardiff UK). No participants 131 
presented a blood glucose over 7 mmol/L and/or a systolic blood pressure over 160 mmHg. 132 
Following recording of preliminary measures, participants completed a graded exercise test 133 
on an incline treadmill (Woodway, Waukeska WI). Participants started at 5 km/h and 4% 134 
incline, and gradually increased treadmill speed (1 km/h/min-1) and treadmill incline (1 135 
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%/min-1) in order to achieve a target RPE of 16 (Borg’s Perceived Rate of Exertion). 136 
Participants wore a Polar Electro heart rate monitor (Polar, Finland) throughout preliminary 137 
and intervention exercise testing periods to quantitatively monitor work rate alongside RPE. 138 
Average HR was measured as 170 ± 6 bpm after participants achieved an RPE score of 16. 139 
 140 
Study design 141 
A within-groups, double blind, crossover design was used to compare the effects of green tea 142 
extract to a placebo, and to a resting condition. A familiarisation visit took place prior to 143 
participant completion of three randomly ordered experimental trials. The experimental trials 144 
included (1) resting conditions (REST), (2) acute exercise with GTE (EX-GTE), and (3) 145 
acute exercise with a placebo (EX-PLAC). All trials were conducted in the morning 146 
following an overnight fast (10-12 hrs). At least 3 days separated each trial day (5.7 ± 1.7 147 
days), acting as a washout period. 148 
 149 
Supplementation  150 
Participants were provided with capsules prior to each exercise trial of either decaffeinated 151 
GTE powder (EGCg Green Tea Extract, Now Foods, Bloomingdale IL) or a plain-flour 152 
placebo to colour match the capsules, and then the opposing capsules the following exercise 153 
test day.  154 
 155 
Due to the pharmacokinetic evidence that the bioavailability of ingested catechins is greater 156 
in a fasted state (Chow et al., 2005), and considering a half-life of ~4 hr (Lee et al., 2002), 157 
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participants were asked to ingest each capsule with 500 ml of water ~1 hr before the provided 158 
dextrose solution, and also ~1 hr before breakfast, lunch and dinner the day prior to each trial 159 
day. Therefore, participants ingested a total of 4 GTE capsules, and 4 PLA capsule each. 160 
Each 400 mg GTE capsule (98% total polyphenols, 80% catechins, 50% EGCG) contained 161 
320 mg of catechins per capsule.   162 
 163 
 164 
Study controls 165 
Participants were asked to maintain a habitual diet, and to not consume alcohol or excessive 166 
amounts of caffeine the day before each trial. A 24-hr food diary was completed by each 167 
participants on these days to monitor intake. Participants were also asked not to perform any 168 
exercise the day prior to each trial.  169 
 170 
Experimental protocol  171 
The resting trial consisted of a 5-minute sitting rest period followed by a 2-hr oral glucose 172 
tolerance test (OGTT). OGTT protocol involved a baseline capillary blood sample (minute 0) 173 
followed by the ingestion of a 250 ml 75g oral glucose beverage (Dextrose powder, 174 
MyProtein Ltd., Cheshire UK) in a fasted state (10-12 hr overnight fast), then capillary blood 175 
sampling for 2 hrs following ingestion (at minutes 15, 30, 45, 60, 90, 120).  176 
 177 
After preliminary testing, each participant’s treadmill speed and incline was noted, after 178 
achieving an RPE score of 16 (speed: 7.92 ± 0.56 km/h; incline 6.88 ± 1.17 %). The trial 179 
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exercise protocol consisted of 6 x 1-min long bouts at a speed that elicited an RPE of 16, 180 
interspersed with ‘slow’ walking (4.8 km/h (3 mph)) for 1-min (total exercise time = 12 181 
mins). This exercise protocol was modified from the work of Francois et al. (2014), who 182 
found ‘exercise snacking’ to be a time-efficient and effective approach to improve glycaemic 183 
control. RPE was used as a simple and inexpensive alternative to HRmax as it is easier to 184 
measure in a real-world setting. This study aimed for participants to achieve an RPE score of 185 
16 (hard - very hard) to mimic the research of Francois et al. (2014) which targeted a measure 186 
of 90% HRmax. A typical RPE response in the Francois et al. (2014) study resulted in the 187 
mean RPE of 16 in high-intensity bouts 4-6, this is in accordance with the work of Francois 188 
and Little (2015) which suggests its take ~3-4 intervals to accurately determine intensity. 189 
Following the exercise bout, a baseline blood glucose sample was taken prior to the 190 
administration of the oral glucose load and 2-hr OGTT.  191 
 192 
Statistical analysis 193 
A sample size calculation was conducted using a custom made spreadsheet (Will Hopkins; 194 
www.sportsci.org), based on glucose AUC reproducibility data from previous work (Gordon 195 
et al., 2011), who found increases greater than 63.5 mmol/L-1.120 min-1 and decreases greater 196 
than 80.9 mmol/L-1.120 min-1 to exceed daily variation. A between subject standard deviation of 197 
100 mmol/L-1.120 min-1 was taken from Venables et al. (2008), and a within subject standard 198 
deviation of 98 mmol/L-1.120 min-1 was calculated by taking 13% (upper 95% CI of normal 199 
daily variation; Gordon et al., 2011) of the average glucose AUC reported by Venables et al. 200 




Glucose area under the curve (AUC) was calculated using the incremental method. All data 203 
were log-transformed prior to analysis. The descriptive summary for all variables comprised 204 
of the geometric mean and dispersion shown as standard deviation (SD) (Hopkins et al., 205 
2009). An analysis of variance (ANOVA) model was used on peak and AUC glucose data. 206 
Following this, a magnitude-based inferences approach (Hopkins et al., 2009), was used to 207 
analyse the mean effect of the intervention (EX-GTE), versus placebo (EX-PLAC) and rest 208 
(REST). Inferences were based on the disposition of the 90% confidence limits (CL) for the 209 
mean difference to the minimal clinically important difference (MCID). Log-transformed 210 
data were back transformed to provide percent differences between conditions. The 211 
probability (percent chances) that differences in glucose AUC between EX-GTE, EX-PLAC 212 
and REST were beneficial (>MCID), harmful (>MCID with opposite sign), or trivial (within 213 
± MCID) was calculated (Hopkins et al., 2009). Robust clinical data for the MCID on all 214 
variables is scarce, therefore, MCID was determined using a standardised mean difference of 215 
0.2 times between subjects’ standard deviations (Cohen, 1988). Subsequently, the percent 216 
chances were defined via probabilistic terms assigned using the following scale; <0.5%, most 217 
unlikely or almost certainly not; 0.5 to 5%, very unlikely; 5 to 25%, unlikely or probably not; 218 
25 to 75%, possibly; 75 to 95%, likely or probably; 95 to 99.5%, very likely; >99.5%, most 219 
likely or almost certainly (Batterham and Hopkins, 2006). Inferences were categorised as 220 
clinical, with the default probabilities for declaring an effect clinically beneficial being <0.5% 221 
(most unlikely) for harm and >25% (possibly) for benefit (Hopkins et al., 2009). 222 
Additionally, in the case of an effect being possibly beneficial (>25%) an unacceptable risk 223 






Results  228 
 229 
The heart rate (170 ± 13 vs. 166 ± 13 beats.min-1) and RPE (13 ±2 vs. 14 ± 2) were 230 
comparable between exercise trials. Comparison between conditions for glucose AUC and 231 
peak glucose can be seen in Table 1. When compared to the REST condition (775.30 ± 86.76 232 
mmol/L-1.120 min-1), there was a most likely beneficial effect of EX-GTE (702.18 ± 76.90 233 
mmol/L-1.120 min-1) on glucose AUC and a very likely beneficial effect compared to EX-234 
PLAC (772.04 ± 81.53 mmol/L-1.120 min-1). The effect was unclear between EX-PLAC and 235 
REST. The average response to the OGTT at all time points is presented in Fig 1. There was 236 
a very likely beneficial effect of EX-GTE (7.51 ± 0.91 mmom/L) when compared to REST on 237 
peak glucose (8.30 ± 0.92 mmol/L). The effect was unclear on all other outcomes. 238 
 239 
 [Insert Figure 1.] 240 
    241 
Discussion 242 
 243 
This study aimed to investigate the effect of high-intensity walking exercise on glycaemic 244 
control, and any additive effect of an acute GTE supplementation strategy. The main finding 245 
was that the walking exercise alone did not influence the glycaemic response during a 2-h 246 
OGTT, but the combined walking exercise with GTE had a 'most likely', and 'very likely' 247 




Previous research has suggested that high-intensity interval walking may be effective at 250 
reducing mean postprandial blood glucose concentrations (Francois et al., 2014; Jakobsen et 251 
al., 2016). Francois et al. (2014) reported that 6 x 1 min bouts of inclined interval walking 252 
(90% HRmax) interspersed with periods of slow walking significantly reduced mean 3 hr 253 
postprandial glucose before breakfast (-1.4 ± 1.5 mmol/L, p = 0.02) when compared to 254 
traditional continuous exercise (30 min moderate-intensity; 60% HRmax), a 17% reduction in 255 
3 hr post-breakfast AUC (interval walking: 1,090 ± 178 mmol/l vs. continuous exercise: 256 
1,307 ± 337, p = 0.04) . The present study aimed to emulate the exercise protocol of Francois 257 
et al. (2014) whilst using RPE to measure effort, as opposed to HRmax, to give a reliable 258 
(Ciolac et al., 2015) but simple and inexpensive method that could be replicated more easily 259 
in the real world,  to simplify the translation of our findings to practice. However, this study 260 
did not find a worthwhile effect between postprandial glucose concentrations of exercise 261 
alone with placebo and the resting condition. More specifically, we aimed for participants to 262 
achieve an RPE score of 16 throughout exercise testing, in an attempt to replicate the 90% 263 
HR max targeted by Francois et al. (2014). However, average trial RPE failed to give the 264 
desired effect (RPE = 16) with an average RPE score of 13.4 ± 1.7 (HR: 170 ± 13.1 bpm) and 265 
13.7 ± 1.6 (HR: 165.8 ± 13 bpm) during the EX-PLAC and EX-GTE trials, respectively. 266 
Moreover, the average HR during the high-intensity intervals was 170 ± 6, ~85% of HRmax, 267 
lower than the desired 90% of HRmax (~178 bpm, p < 0.01).  This suggests that the study 268 
duration, and/or intensity may not have been high enough to induce the desired physiological 269 
changes. Similarly, Jakobsen et al. (2016) suggest that altering the intervention to 3 min long 270 
bouts of high-intensity walking may improve glycaemic control, specifically, by reducing 271 
postprandial glucose concentrations. The study found no difference between mean glucose 272 
after 1 min walking cycles compared to control, whereas 3 min bouts attenuated glucose 273 
response following a 4 hr liquid mixed meal tolerance test. The inclusion of a step test in 274 
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place of a ramp test would be recommended in future, with sufficient breaks between steps to 275 
reduce the effect of cumulative fatigue during the graded exercise test and increase the 276 
walking speed at an RPE of 16. Whilst the current study found no benefit to high-intensity 277 
interval walking alone for glycaemic control, these results are contrary to the limited previous 278 
research.  279 
 280 
The addition of GTE to the walking intervention did reduce postprandial glucose 281 
concentrations, and the ~9% reduction in glucose AUC in the EX-GTE trial can be 282 
interpreted as being ‘most likely beneficial’ compared to REST and ‘very likely beneficial’ 283 
compared to exercise alone (Table 1). The effect of this intervention was greater than the 284 
typical 6% daily variation of OGTT results identified by Gordon et al. (2011). This would 285 
suggest that the study intervention may improve insulin sensitivity of the skeletal muscle, 286 
agreeing with the work of Martin et al. (2016) who suggest that GTE may alter skeletal 287 
muscle glucose uptake in humans. Possibly due to the increased translocation of glucose 288 
transporters which is apparent in rodent studies, specifically, green tea has shown to have a 289 
similar effect to exercise, in that, prolonged consumption increases GLUT-4 translocation in 290 
normal and insulin resistant skeletal muscle, in addition to increased adipocyte insulin-291 
receptor binding (Wu et al., 2004).  292 
 293 
A limitation of the present study is the absence of a GTE group without the exercise 294 
intervention to give further context to the combined effect of GTE and exercise, however, 295 
previous research has indicated that GTE alone may not sufficiently reduce postprandial 296 
glucose concentrations. As mentioned, Martin et al. (2016) state that GTE attenuated glucose 297 
response to an oral glucose load following acute exercise, however, the study found no effect 298 
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under resting conditions (Glucose AUC: GTE = 394 ± 70, PLA = 409 ± 78 mmol/L-1·60 min-299 
1, p = 0.51). Venables et al. (2008) also found that GTE significantly lowered insulin AUC (-300 
15 ± 4%, p < 0.01)  and increased insulin sensitivity (insulin sensitivity index (ISI): 13 ± 4%, 301 
p < 0.05), albeit with no difference in glucose concentrations (p > 0.05). Furthermore, a 302 
combined intervention should be recommended where possible due to the further reaching 303 
benefits of physical activity. Importantly, this study presents evidence that a combined 304 
walking and GTE intervention can improve glycaemic control. This offers insight in to a 305 
potentially more real world applicable and achievable exercise in physically inactive people 306 
than has been researched in the past, as previous studies have for example used higher 307 
intensity cycling protocols (Little et al., 2011; Whyte et al., 2010). It should also be 308 
considered when interpreting our results that although the participants were physically 309 
inactive, their glycaemic control was good under all testing conditions, and fasted blood 310 
glucose was 4.41 ± 0.17 mmol/L. The results may be different in populations with poorer 311 
glycaemic control, and further research is warranted in this area. 312 
 313 
In conclusion low-volume interval-walking exercise combined with GTE supplementation 314 
was found to reduce postprandial glucose concentrations in physically inactive individuals. A 315 
combined walking and green tea routine may be an achievable and translatable intervention 316 
for physically inactive people.  317 
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Figure caption 434 
Fig 1. Average post-prandial blood glucose (mmol/L) response at each time point of the OGTT 435 




















Table 1 Clinical inferences of differences in glycaemic control between treatment groups  454 
Variable Comparison Difference between 
groups  
(% mean; 90%CL) 
Likelihood (%) of 
intervention being  





EX-GTE to REST -9.4 ±4.9 99.8 / 0.1 / 0.1 Most likely beneficial 
EX-GTE to EX-PLAC -9.1 ±7.1 98.0 / 0.0 / 2.0 Very likely beneficial 









98.2 / 0.0 / 1.7 
 
Very likely beneficial 
EX-GTE to EX-PLAC -7.23 ±12 84.1 / 0.2 / 15.2 Unclear 
 EX-PLAC to REST -2.79 ±50 53.7 / 0.1 / 46.2 Unclear 
AUC = area under the curve; REST = resting condition; EX-PLAC = exercise intervention with placebo; EX-GTE 
exercise intervention with green tea extract supplementation 
22 
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